Kellerhals Carrard represented Moderna biotechnology company as it was heard as a third party in the inspection of the Control Committee of the National Council (CC-N) that was launched in May 2020 regarding the handling of
Kellerhals Carrard represented Moderna biotechnology company as it was heard as a third party in the inspection of the Control Committee of the National Council (CC-N) that was launched in May 2020 regarding the handling of